Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the Best Biotech Stocks. On April 23, Reuters reported that the U.S.

FDA approves Otarmeni gene therapy for genetic hearing loss; Regeneron offers free treatment, restoring hearing by correcting OTOF mutations.

The African Centre for Biodiversity found traces of glyphosate in SA baby cereal, bread, maize meal and wheat flour, with two ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the Best Biotech Stocks. On April 23, Reuters reported that the U.S.

Shlagel Farms strikes that balance beautifully. One of the best aspects of visiting this farm is that it works for literally ...

The fight against malaria may soon take a futuristic turn. Scientists are now exploring genetically altered mosquitoes as a powerful tool to curb the spread of this life-threatening infection, which ...

Researchers successfully implanted a genetically modified pig liver into a human, proving that such an organ can function for an extended period. The graft supported essential liver processes before ...

Researchers say risk comes from ‘other factors, including genetic predisposition to mental health conditions’ ...

Sam Levinson’s HBO show has always aimed to ruffle feathers. But its new season’s provocations ring hollow ...

Prospective parents can now pick embryos based on risk predictions for thousands of diseases and odds for specific traits.

Nearly 10% of US births in 2023 came from illegal immigrant mothers, according to newly published research. Pew Research Center revealed that 320,000 of the 3.6 million babies born in the US that year ...